DK0382276T3 - Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer - Google Patents

Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer

Info

Publication number
DK0382276T3
DK0382276T3 DK90200167.6T DK90200167T DK0382276T3 DK 0382276 T3 DK0382276 T3 DK 0382276T3 DK 90200167 T DK90200167 T DK 90200167T DK 0382276 T3 DK0382276 T3 DK 0382276T3
Authority
DK
Denmark
Prior art keywords
indazole
hydroxymethyl
ethers
benzyl
aliphatic
Prior art date
Application number
DK90200167.6T
Other languages
Danish (da)
English (en)
Inventor
Bruno Silvestrini
Leandro Baiocchi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of DK0382276T3 publication Critical patent/DK0382276T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK90200167.6T 1989-02-07 1990-01-23 Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer DK0382276T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (1)

Publication Number Publication Date
DK0382276T3 true DK0382276T3 (da) 1996-01-15

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90200167.6T DK0382276T3 (da) 1989-02-07 1990-01-23 Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer

Country Status (36)

Country Link
US (2) US4999367A (enExample)
EP (1) EP0382276B1 (enExample)
JP (1) JP2870925B2 (enExample)
KR (1) KR0145525B1 (enExample)
CN (2) CN1046505C (enExample)
AR (1) AR247386A1 (enExample)
AT (1) ATE127115T1 (enExample)
AU (1) AU624895B2 (enExample)
BG (1) BG50273A3 (enExample)
CA (1) CA2009503C (enExample)
CZ (1) CZ280121B6 (enExample)
DD (2) DD295363A5 (enExample)
DE (2) DE69021902T2 (enExample)
DK (1) DK0382276T3 (enExample)
EG (1) EG19170A (enExample)
ES (1) ES2020171T3 (enExample)
FI (1) FI102678B (enExample)
GE (1) GEP19971030B (enExample)
GR (2) GR910300073T1 (enExample)
HU (1) HU204793B (enExample)
IL (1) IL93132A (enExample)
IN (1) IN170957B (enExample)
IT (1) IT1230441B (enExample)
LT (1) LT3604B (enExample)
LV (1) LV10612B (enExample)
NZ (1) NZ232258A (enExample)
PE (1) PE25091A1 (enExample)
PH (1) PH26552A (enExample)
PL (2) PL163730B1 (enExample)
PT (1) PT93067B (enExample)
RO (1) RO106252B1 (enExample)
RU (3) RU2066318C1 (enExample)
SK (1) SK56390A3 (enExample)
UA (1) UA26852C2 (enExample)
YU (1) YU47943B (enExample)
ZA (1) ZA90644B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) * 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EP2262778B8 (en) 2008-03-07 2020-01-01 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
US8314099B2 (en) 2008-03-07 2012-11-20 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
PL2254870T3 (pl) * 2008-03-07 2016-07-29 Acraf Pochodne 1-benzylo-3-hydroksymetyloindazolu i ich zastosowanie w leczeniu chorób opartych na ekspresji MCP-1, CX3CR1
PL2462119T3 (pl) * 2009-08-03 2014-10-31 Acraf Sposób wytwarzania 1-benzylo-3-hydroksymetylo-1H-indazolu i jego pochodnych oraz potrzebnych magnezowych związków pośrednich
UA108742C2 (uk) * 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
EP2844250B1 (en) 2012-05-01 2017-11-08 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
JP2015521183A (ja) 2012-05-18 2015-07-27 サノフイ ピリジン誘導体および病理学的血栓形成に関連する状態の治療へのその使用
EP2882715B1 (en) 2012-05-18 2016-11-09 Sanofi Pyrazole derivatives and their use as lpar5 antagonists
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
EP3990433A4 (en) 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
LV10612B (en) 1995-08-20
ES2020171A4 (es) 1991-08-01
PL163730B1 (pl) 1994-04-29
FI900577A0 (fi) 1990-02-06
YU20690A (sh) 1992-07-20
IT8947620A0 (it) 1989-02-07
IL93132A (en) 1994-05-30
DD295363A5 (de) 1991-10-31
PT93067B (pt) 1995-12-29
SK278441B6 (en) 1997-05-07
RU2044729C1 (ru) 1995-09-27
CZ280121B6 (cs) 1995-11-15
YU47943B (sh) 1996-07-24
DD291995A5 (de) 1991-07-18
ATE127115T1 (de) 1995-09-15
AU624895B2 (en) 1992-06-25
SK56390A3 (en) 1997-05-07
CN1046505C (zh) 1999-11-17
CA2009503A1 (en) 1990-08-07
BG50273A3 (en) 1992-06-15
LTIP872A (en) 1995-03-27
HU204793B (en) 1992-02-28
EP0382276B1 (en) 1995-08-30
HU900689D0 (en) 1990-04-28
IT1230441B (it) 1991-10-23
AU4906690A (en) 1990-08-16
ES2020171T3 (es) 1995-12-01
DE69021902T2 (de) 1996-05-23
ZA90644B (en) 1991-01-30
LV10612A (lv) 1995-04-20
RO106252B1 (ro) 1993-03-31
PE25091A1 (es) 1991-08-17
DE382276T1 (de) 1991-11-28
US5112986A (en) 1992-05-12
CN1044810A (zh) 1990-08-22
RU2055071C1 (ru) 1996-02-27
EP0382276A3 (en) 1990-12-12
EP0382276A2 (en) 1990-08-16
GEP19971030B (en) 1997-06-13
PT93067A (pt) 1990-08-31
CN1088201A (zh) 1994-06-22
JP2870925B2 (ja) 1999-03-17
KR0145525B1 (ko) 1998-08-17
IL93132A0 (en) 1990-11-05
FI102678B1 (fi) 1999-01-29
UA26852C2 (uk) 1999-12-29
DE69021902D1 (de) 1995-10-05
NZ232258A (en) 1991-06-25
KR900012913A (ko) 1990-09-03
LT3604B (en) 1995-12-27
PH26552A (en) 1992-08-19
CN1034016C (zh) 1997-02-12
CZ56390A3 (en) 1995-06-14
US4999367A (en) 1991-03-12
CA2009503C (en) 2000-04-11
EG19170A (en) 1994-11-30
JPH02240065A (ja) 1990-09-25
AR247386A1 (es) 1994-12-29
FI102678B (fi) 1999-01-29
RU2066318C1 (ru) 1996-09-10
GR3018165T3 (en) 1996-02-29
GR910300073T1 (en) 1991-11-15
HUT53088A (en) 1990-09-28
PL163720B1 (pl) 1994-04-29
IN170957B (enExample) 1992-06-20

Similar Documents

Publication Publication Date Title
DK0382276T3 (da) Ethere af 1-benzyl-3-hydroxymethyl-indazol med alifatiske 2-hydroxysyrer
DK148885A (da) Stabilt praeparat af interleukin-2
DK199384D0 (da) Balle af straa eller hoe
DK0485436T3 (da) Fremgangsmåde til fremstilling af et næringsmiddel med reduceret fedtstofindhold
DK196986D0 (da) Fremstilling af polysaccharider
DK237187A (da) Farmaceutisk anvendelse af t-pa
DK193588D0 (da) Anvendelser af dopaminagonister
DK363887D0 (da) Anvendelse af bromcruptin
DK0537786T3 (da) Fremstilling af en N-acylaminomethylphosphonsyre
DK427787A (da) Komponenter af plastmateriale
DK0408845T3 (da) Vakuumafkøling af kød
DK529583D0 (da) Enzymatisk fremstilling af l-serin
DK70486D0 (da) Fremstilling af polypeptider
DK130390A (da) Praeparat af i prokaryonter udtrykt plasminogenaktivator
DK88091A (da) Fremstilling af pentansyrederivater
DK420185A (da) Anvendelse af somatostatinanaloge
DK426089D0 (da) Omestring af phospholipider
ES542550A0 (es) Procedimiento de preparacion de campos de deporte
DK73687D0 (da) Hydroxaminsyrer af 7-oxabicycloheptansubstituerede ethere
DK487289D0 (da) Omestring af phospholipider
DK135387D0 (da) Fremstilling af proteiner
FI914832A7 (fi) 4-metyylitiatsolin valmistus
DK519287A (da) Praeparat med thrombolytisk virkning
DK345683D0 (da) Fremstilling af 2-t-butyl-5-chlorpyrimidin
DK321986A (da) Fremstilling af proteiner